171 related articles for article (PubMed ID: 34931722)
1. Position paper on a simplified histopathological classification of basal cell carcinoma: results of the European Consensus Project.
Fernández-Figueras MT; Malvehi J; Tschandl P; Rutten A; Rongioletti F; Requena L; Kittler H; Kerl K; Kazakov D; Cribier B; Calonje E; André J; Kempf W;
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):351-359. PubMed ID: 34931722
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic concordance rates in the subtyping of basal cell carcinoma by different dermatopathologists.
Nedved D; Tonkovic-Capin V; Hunt E; Zaidi N; Kucenic MJ; Graves JJ; Fraga GR
J Cutan Pathol; 2014 Jan; 41(1):9-13. PubMed ID: 24152016
[TBL] [Abstract][Full Text] [Related]
3. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
5. Inter-rater concordance of basal cell carcinoma subtypes: influences on reporting format and opportunities for further classification modifications.
Maher NG; Prosser N; Aivazian K; Colebatch AJ; Ferguson PM; Karim RZ; McKenzie CA; Rawson RV; Lo SN; Scolyer RA
Pathology; 2023 Oct; 55(6):800-805. PubMed ID: 37393148
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
Kiely JR; Patel AJK
J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
8. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
[TBL] [Abstract][Full Text] [Related]
9. Dermoscopic Clues of Histopathologically Aggressive Basal Cell Carcinoma Subtypes.
Camela E; Ilut Anca P; Lallas K; Papageorgiou C; Manoli SM; Gkentsidi T; Eftychidou P; Liopyris K; Sgouros D; Apalla Z; Lallas A
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837550
[No Abstract] [Full Text] [Related]
10. Clinical and histopathological characteristics of basal cell carcinoma in Chinese patients.
Chang JM; Gao XM
Chin Med J (Engl); 2013 Jan; 126(2):211-4. PubMed ID: 23324265
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma: a dermatopathological and molecular biological update.
Saldanha G; Fletcher A; Slater DN
Br J Dermatol; 2003 Feb; 148(2):195-202. PubMed ID: 12588368
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
13. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma.
Kamyab-Hesari K; Seirafi H; Naraghi ZS; Shahshahani MM; Rahbar Z; Damavandi MR; Naraghi MM; Rezvani M; Aghazadeh N
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):250-3. PubMed ID: 22989368
[TBL] [Abstract][Full Text] [Related]
15. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
Sohn GK; Keniston K; Kannan S; Hinds B; Jiang SIB
J Drugs Dermatol; 2021 Mar; 20(3):283-288. PubMed ID: 33683071
[TBL] [Abstract][Full Text] [Related]
17. High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases.
Wolberink EA; Pasch MC; Zeiler M; van Erp PE; Gerritsen MJ
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):985-9. PubMed ID: 22759209
[TBL] [Abstract][Full Text] [Related]
18. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.
Kaur P; Mulvaney M; Carlson JA
Am J Dermatopathol; 2006 Aug; 28(4):293-307. PubMed ID: 16871032
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Biopsy in Subtyping Periocular Basal Cell Carcinoma.
Sun MT; Wu A; Huilgol SC; Selva D
Ophthalmic Plast Reconstr Surg; 2015; 31(6):449-51. PubMed ID: 25794023
[TBL] [Abstract][Full Text] [Related]
20. [Not Available].
Cribier B
Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS3-VS11. PubMed ID: 30477681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]